Ciena Operating Cash Flow decreased by 38.7% to $227.65M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 119.5%, from $103.72M to $227.65M. Over 2 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 22.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $224.98M | $69.10M | $254.89M | -$54.41M | $106.55M | -$205.39M | -$14.51M | -$265.64M | $195.47M | $266.08M | $58.47M | $349.36M | $103.72M | $156.95M | $174.35M | $371.08M | $227.65M |
| QoQ Change | — | -69.3% | +268.9% | -121.3% | +295.8% | -292.8% | +92.9% | <-999% | +173.6% | +36.1% | -78.0% | +497.5% | -70.3% | +51.3% | +11.1% | +112.8% | -38.7% |
| YoY Change | — | — | — | — | -52.6% | -397.2% | -105.7% | -388.2% | >999% | +200.2% | — | +78.7% | -61.0% | +168.4% | — | +6.2% | +119.5% |